Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Global Boron Carbide Market was valued at US$ 314.11 million in 2023 and is projected to hit the market valuation of US$ 457.84 million by 2032 at a CAGR of 4.49% during the forecast period 2024–2032.